Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
A French research trial aims to assemble a biological collection to develop preclinical translational models for tumors and chronic liver di…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection [Phase 2]
A Phase 2 study evaluating eltrombopag for immune thrombocytopenia in patients with chronic hepatitis B infection has completed.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stopping Antiviral Treatment in Chronic Hepatitis B
This clinical trial update discusses stopping antiviral therapy in chronic hepatitis B. The study is sponsored by The University of Hong Kon…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) [Phase 2]
Phase 2 trial update describing a study that compares ALG-000184 with tenofovir disoproxil fumarate in untreated adults with chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo
The trial update describes the MAGIA H3S point-of-care test being evaluated for HIV, hepatitis B and C, and syphilis screening in pregnant w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) [Phase 2]
Phase 2 study of bepirovirsen for hepatitis B in participants living with HIV and chronic hepatitis B infection; the trial is currently acti…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C [NA]
Prospective clinical performance evaluation of the MaGIA IBC point-of-care device for combined screening of HIV, Hepatitis B, and Hepatitis …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Clinical performance evaluation of MagIA's multiplex HIV, HBV, HCV, and syphilis testing is ongoing, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: HepB mAb19 in Individuals With Chronic Hepatitis B Infection [Phase 1]
This update indicates that a Phase 1 clinical trial of HepB mAb19 for chronic hepatitis B infection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B [Phase 1, Phase 2]
This clinical trial update announces a Phase 1/2 open-label study of CRMA-1001 in adults with chronic hepatitis B, evaluating single and mul…
-
EMA approval · 2026-01-28EMA Authorised: Heplisav B (hepatitis B surface antigen) — Dynavax GmbH
The European Medicines Agency authorised Heplisav B, a hepatitis B vaccine based on hepatitis B surface antigen, for use in the European Uni…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
A Phase 2 study evaluated adding TQA3605 to nucleoside analogs for chronic hepatitis B virus infection with low-level viremia; the trial has…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B [Phase 1]
Phase 1 clinical trial evaluating the HBV therapeutic vaccines GS-2829 and GS-6779 in healthy participants and individuals with Chronic Hepa…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment [Phase 3]
Phase 3 trial to evaluate GST-HG141 in adults with chronic hepatitis B who have an inadequate response to antiviral therapy; study is curren…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7565020 in healthy volunteers and individuals wit…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
A clinical trial update describing a University of Pennsylvania study on immune regulation and costimulation in the natural history and ther…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
University of Pennsylvania is conducting the HBRN study on immune regulation and costimulation in the natural history of chronic hepatitis B…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. [Phase 4]
Phase 4 clinical trial update on managing hepatitis B and HPV-related cancers and associated mental health conditions. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
A completed clinical trial evaluating the epidemiology of hepatitis B virus in a representative sample of adults in Zambia, sponsored by the…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children [Phase 4]
A Phase 4 clinical trial comparing immunogenicity of two-dose versus three-dose schedules of combined Hepatitis B vaccines in children aged …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
A clinical trial at West Virginia University aims to rapidly screen people for HIV, hepatitis C, syphilis, and hepatitis B in a rural street…
-
EMA approval · 2026-01-16EMA Authorised: Entecavir Viatris (previously Entecavir Mylan) (entecavir monohydrate) — Viatris Limited
The EMA authorised Entecavir Viatris (entecavir monohydrate) for the treatment of chronic hepatitis B.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial evaluating entecavir with or without pegylated interferon alfa-2b in children aged 3-6 with immune-active chronic h…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B [Phase 4]
A Phase 4 trial to evaluate entecavir with or without pegylated interferon alpha-2b in children aged 3-6 with immune-tolerant chronic hepati…